Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials
Samiksha Gupta, Rana Prathap Padappayil, Agam Bansal, Salim Daouk, Brent Brown
DOI: 10.1136/jim-2021-002001 Published 24 September 2021
Samiksha Gupta
1Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
Rana Prathap Padappayil
2Department of Internal Medicine, Monmouth Medical Center, Long Branch, New Jersey, USA
Agam Bansal
3Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
Salim Daouk
4Department of Pulmonary Medicine and Critical Care, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
Brent Brown
4Department of Pulmonary Medicine and Critical Care, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
No eLetters have been published for this article.
Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials
Samiksha Gupta, Rana Prathap Padappayil, Agam Bansal, Salim Daouk, Brent Brown
Journal of Investigative Medicine Sep 2021, jim-2021-002001; DOI: 10.1136/jim-2021-002001
Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials
Samiksha Gupta, Rana Prathap Padappayil, Agam Bansal, Salim Daouk, Brent Brown
Journal of Investigative Medicine Sep 2021, jim-2021-002001; DOI: 10.1136/jim-2021-002001